使用现成胸主动脉分支覆膜支架对主动脉再缩窄及缩窄后降主动脉胸段动脉瘤的分支腔内修复
本病例报告描述使用现成胸主动脉分支覆膜支架对术后再缩窄的主动脉及狭窄后降主动脉胸段动脉瘤进行经皮腔内修复。该支架并入左锁骨下动脉,成功解除主动脉压力阶差并完全隔绝动脉瘤。文章强调该现成支架在胸主动脉缩窄超说明书使用中的独特技术要点,认为其是邻近左锁骨下动脉病变的理想腔内选择。
要点
- 现成胸主动脉分支覆膜支架可经皮修复术后再缩窄及狭窄后降主动脉胸段动脉瘤。
- 支架并入左锁骨下动脉,成功解除主动脉压力阶差并完全隔绝动脉瘤。
- 该支架为邻近左锁骨下动脉的胸主动脉缩窄病变提供了理想腔内选择。
核心结论
- 使用现成胸主动脉分支覆膜支架经皮修复术后再缩窄及狭窄后降主动脉胸段动脉瘤,成功解除主动脉压力阶差并完全隔绝动脉瘤。
研究设计与样本
- 病例报告,描述一例术后再缩窄的主动脉及狭窄后降主动脉胸段动脉瘤的经皮腔内修复。
主要发现
- 使用现成胸主动脉分支覆膜支架并入左锁骨下动脉,成功解除主动脉压力阶差并完全隔绝动脉瘤。
临床怎么用
- 文章强调该现成支架在胸主动脉缩窄超说明书使用中的独特技术要点,并认为其是邻近左锁骨下动脉病变的理想腔内选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent coarctation of the aorta (reCoA) can be treated via redo surgical or endovascular means with the latter option providing a shorter hospitalization, expedient recovery, and a lower incidence of early morbidity and mortality. A common barrier to endovascular repair with standard thoracic endografts is the proximity of the left subclavian artery (LSA) to the reCoA which has previously necessitated adjunctive open revascularization or additional off-label endovascular techniques. This case describes percutaneous endovascular repair of postsurgical reCoA and a poststenotic descending thoracic aortic aneurysm with an off-the-shelf thoracic branched endograft incorporating the LSA with successful resolution of aortic pressure gradient and complete aneurysm exclusion.Clinical ImpactThis case highlights the use of a commercially available, off-the-shelf endograft to treat thoracic aortic coarctation and associated aortic aneurysm. The paper highlights unique technical points for use of the Gore Thoracic Branch Endoprosthesis in the off-label treatment of thoracic aortic coarctation which is an ideal endovascular option for lesions in proximity to the left subclavian artery.
引用
- Chait J, Anderson JH, Varol M, et al. Branched Endovascular Repair of Aortic Recoarctation and Postcoarctation Descending Thoracic Aortic Aneurysm With the Off-the-Shelf Thoracic Branch Endoprosthesis. J Endovasc Ther. 2025. PMID: 40123418. doi:10.1177/15266028251328459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。